Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
Psychosomatics
|
September 29, 2014
Olanzapine for the treatment of psychiatric illness and urticaria: a case report
Yankel J Girshman, Ying Wang, Alan Mendelowitz
Biophysical Journal
|
September 1, 1997
Gramicidin channels in phospholipid bilayers with unsaturated acyl chains
J Girshman, D V Greathouse, R E Koeppe, et al.
Biochemistry
|
March 26, 1996
Membrane stiffness and channel function
J A Lundbaek, P Birn, J Girshman, et al.
The Psychiatric Quarterly
|
March 23, 2015
Medical Rapid Response in Psychiatry: Reasons for Activation and Immediate Outcome
Peter Manu, Kristy Loewenstein, Yankel J Girshman, et al.
The Psychiatric Quarterly
|
June 10, 2015
Erratum to: Medical Rapid Response in Psychiatry: Reasons for Activation and Immediate Outcome
Peter Manu, Kristy Loewenstein, Yankel J Girshman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2019
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
A J Schoenfeld, K C Arbour, H Rizvi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
Psychosomatics
|
September 29, 2014
Olanzapine for the treatment of psychiatric illness and urticaria: a case report
Yankel J Girshman, Ying Wang, Alan Mendelowitz
Biophysical Journal
|
September 1, 1997
Gramicidin channels in phospholipid bilayers with unsaturated acyl chains
J Girshman, D V Greathouse, R E Koeppe, et al.
Biochemistry
|
March 26, 1996
Membrane stiffness and channel function
J A Lundbaek, P Birn, J Girshman, et al.
The Psychiatric Quarterly
|
March 23, 2015
Medical Rapid Response in Psychiatry: Reasons for Activation and Immediate Outcome
Peter Manu, Kristy Loewenstein, Yankel J Girshman, et al.
The Psychiatric Quarterly
|
June 10, 2015
Erratum to: Medical Rapid Response in Psychiatry: Reasons for Activation and Immediate Outcome
Peter Manu, Kristy Loewenstein, Yankel J Girshman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 9, 2019
Severe immune-related adverse events are common with sequential PD-(L)1 blockade and osimertinib
A J Schoenfeld, K C Arbour, H Rizvi, et al.
Page
of 1